美女被啪啪激烈爽到喷水免费,欧美丰满嫩嫩电影,偷拍xxxxx,欧美一区二粉嫩精品国产一线天,国产精品theav,亚洲国产视频在线,亚洲情欲网

SDS
兔腫瘤壞死因子配體超家族成員12(TNFSF12)酶聯(lián)免疫吸附試劑盒
Catalog #: E04S0312
Sample Type: Biological samples

 

Other Names

Rabbit soluble tumor necrosis factor-like weak inducer of apoptosis ELISA Kit

APO3L; DR3LG; TWEAK; APO3 ligand; TNF-related weak inducer of apoptosis

Research Area

Cancer

Background

Tumor necrosis factor ligand superfamily member 12 also known as TNF-related weak inducer of apoptosis (TWEAK) is a protein that in humans is encoded by the TNFSF12 gene.TWEAK was discovered in 1997.The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein is a ligand for the FN14/TWEAKR receptor. This cytokine has overlapping signaling functions with TNF, but displays a much wider tissue distribution. Leukocytes are the main source of TWEAK including human resting and activated monocytes, dendritic cells and natural killer cells.TWEAK can induce apoptosis via multiple pathways of cell death in a cell type-specific manner. This cytokine is also found to promote proliferation and migration of endothelial cells, and thus acts as a regulator of angiogenesis.Excessive activation of the TWEAK pathway in chronic injury has been described to promote pathological tissue changes including chronic inflammation, fibrosis and angiogenesis.In chronic liver disease for example TWEAK expression is enhanced and causes hepatic stellate cells, which are key regulators of liver fibrosis, to proliferate.A disease-driving role of the TWEAK pathway has been described in several other diseases as well. For example, NFAT1 regulates the expression of TWEAKR and its ligand TWEAK (this protein) with lipocalin 2 to increase breast cancer cell invasion.